← brief for 2026-10-02 · Slowing decline

Renoprotective effects and safety of sodium-glucose cotransporter 2 inhibitors in diabetic chronic kidney disease: A systematic review and meta-analysis.

Paper A Peer reviewed Meta-analysis or large trial

Key takeaways

This large review combined data from many trials to check a class of diabetes drugs called SGLT2 inhibitors. It found these drugs are safe and help protect the kidneys in people with diabetes. This is a meta-analysis, which is the strongest type of evidence.

Who did this work

Shi X · Fu K · Hu M · Li R · Li H · Xu S

Source

Paper · PubMed, the drug frontier · 2026 Oct 2
https://pubmed.ncbi.nlm.nih.gov/42826278/